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Abstract: This work was aimed at determining the possible antimicrobial potential of asiatic acid (AA) and ursolic acid (UA) against
clinical uropathogenic Escherichia coli strains (UPECs). Phylogenetic affiliations of UPECs and virulence-associated gene carriage have
been identified. PCR analysis revealed that the studied E. coli strains belong to phylogenetic group B2. All bacterial isolates were grouped
into 4 pathotypes. The following were determined: the minimum inhibitory concentrations (MICs) according to CLSI; P-fimbriae
synthesis, based on erythrocyte agglutination; curli fibers, by using YESCA agar with congo red; swimming motility, in motility agar;
and alpha-hemolysin, on sheep’s-blood agar plates. The differences in antigrowth activities of AA and UA were recorded. Inhibition of
P-fimbriae, curli fibers, and alpha-hemolysin production after exposure of UPECs to both AA and UA were observed. Reduction of
bacterial motility was also noticed. Our results clearly show the influence of AA and UA on virulence factors of UPEC strains. However,
differences between antivirulence activities of AA and UA were not found, although a higher level of antigrowth activity of AA in
comparison with UA was shown.
Key words: Uropathogenic Escherichia coli, asiatic acid, ursolic acid, minimum inhibitory concentration, alpha-hemolysin, curli fibers,
P-fimbriae, motility

1. Introduction
Urinary tract infections (UTIs) are one of the most
common infectious diseases in the human population.
Bacteria are the causative agents responsible for more
than 95% of UTIs. Most of these infections are caused by
uropathogenic Escherichia coli strains UPECs (Foxman,
2010). Several potential virulence factors including
adhesins, motility, and hemolysins may be responsible
for the pathogenicity of UPECs. P-fimbriae and curli
fibers promote UPEC adhesion, which is essential in
colonization of the host tissues during the initial stages of
an infection. P-fimbriae are the most prevalent fimbrial
type of UPEC strains causing pyelonephritis (Stapleton,
2005). The colonization of the urinary system epithelium
requires penetration of the mucus layer; therefore, the
ability to move is a very useful feature of UPECs that
facilitates infection. These bacteria also produce a poreforming alpha-hemolysin, which is an important factor
in causing necrosis of the eukaryotic cells. Many people
suffer from recurrent UTIs; therefore, repeated treatment
with antibiotics may lead to increased resistance of
bacteria (Gupta et al., 2001; Foxman, 2010). To overcome
the problem of antibiotic resistance, medicinal plants have
* Correspondence: dorota.wojnicz@umed.wroc.pl
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been intensively studied as alternative or supplementary
treatment methods against bacterial diseases (Khan et al.,
2009; Mavi et al., 2011; Teyeb et al., 2011; Baykan Erel et
al., 2012; Pehlivan Karakaş et al., 2012). Among various
active substances present in plants, pentacyclic triterpenes
display antibacterial properties (Chung et al., 2011).
Pentacyclic triterpenes are a group of natural
compounds widespread in the plant kingdom (Jager
et al., 2009). Asiatic acid (AA) and ursolic acid (UA)
possess similar chemical structures (Figure 1); both
belong to the aglycone pentacyclic triterpenes. AA is an
important component of the medicinal plant Centella
asiatica (James and Dubery, 2009). UA is found in many
common plants (Ikeda et al., 2008; Yamaguchi et al.,
2008). Many reports describe the antiinflammatory,
hepatoprotective, gastroprotective, antiulcer, anti-HIV,
cardiovascular, hypolipidemic, antiatherosclerotic, and
immunoregulatory activities of AA and UA (Cho et
al., 2006; Jeong et al., 2007; Ikeda et al., 2008). Despite
these reports, their antimicrobial properties have been
poorly investigated. Available reports mainly describe
the activities of pentacyclic triterpene-containing plant
extracts against gram-positive bacteria (Kurek et al., 2010;
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Figure 1. Chemical structures of AA (A) and UA (B). A, B, C, D, E – the names of rings in the molecules.

Chung et al., 2011). To our knowledge, reports describing
the antibacterial activities of pentacyclic triterpenes,
especially against UPECs, have been very limited; this fact
prompted us to perform the current study.
The aim of our study was to evaluate the antimicrobial
activities of AA and UA and their effect on growth,
P-fimbriae, curli fibers, alpha-hemolysin synthesis, and
swimming motility of UPEC strains. We also made an
attempt to determine the correlation between the acids’
structure and their impact on the survival and virulence
factors of tested E. coli rods.
2. Materials and methods
2.1. Bacterial strains
Twenty E. coli clinical strains were isolated from the
urine of patients suffering from pyelonephritis who were
hospitalized in the Academic Clinical Centre of Wroclaw
Medical University. The biochemical species affiliation of
the examined strains was confirmed using the API-20E
test kit (BioMérieux, Poland). The strains were maintained
on Mueller-Hinton agar slopes (Oxoid) at 4 °C.
2.2. Phylogenetic classification and virulence-associated
gene carriage
The detection of specific nucleotide sequences was
confirmed by PCR on the total bacterial DNA using
the GeneMATRIX Bacterial & Yeast Genomic DNA
Purification Kit (EURx, Poland). All PCR analyses were
performed using DreamTaq DNA polymerase (Fermentas,
Germany). Membership of studied strains in a certain
phylogenetic group was determined using primers specific
for 2 genes (chuA and yjaA) and a DNA fragment (TspE4.
C2), according to the methods of Clermont et al. (2000).
PCR assays revealed that 20 E. coli isolates fell into
phylogenetic group B2. Studied strains were also screened
for the presence of genes encoding adhesins (papC, afa,
draE, csgA) and a toxin (hlyA). Sequence coding for 16S
rRNA was used as a positive control. The characteristics of

all used primers, except draE primers, as well as amplicon
lengths, were listed in our previous study (Wojnicz et al.,
2012). Primers 5’-GACAGTTTACTGATTCTGGGA-3’
and 5’-ACGTCCAATAATGCTTACCC-3’ were used in
the PCR analysis to amplify the draE gene (Matar et al.,
2005). The presence of PCR-amplified DNA fragments was
confirmed in 2% agarose gel. Gel images were analyzed
using the Quantity One System (Bio-Rad, USA).
2.3. Antimicrobial agents
AA (purity of ≥97%) and UA (purity of ≥90%) were
purchased from Sigma-Aldrich (Poland). Both acids were
dissolved in 96% ethanol (heated to 70 °C) to obtain 10
mg/mL stock solutions. Final concentrations of AA and
UA were prepared from the stock solutions using MuellerHinton broth (MHB).
2.4. MIC assay
All strains were grown in MHB at 37 °C overnight, resulting
in approximately 108 CFU/mL. The minimum inhibitory
concentrations (MICs) of AA and UA were determined
by the broth microdilution method (CLSI, 2008). Briefly,
stock solutions of triterpenes (10 mg/mL) were dissolved
in MHB to obtain concentrations ranging from 4 to 1024
µg/mL, and then 200 µL of each concentration was added
to each well of a 96-well microplate and incubated with
the examined bacterial strain at 37 °C for 24 h. The lowest
concentration of acid that inhibited bacterial growth was
defined as the MIC. Each assay was repeated 3 times.
2.5. Effect of AA and UA on bacterial growth
The bacteria were grown overnight at 37 °C in MHB.
Next, bacteria were centrifuged and resuspended in
phosphate-buffered saline (PBS) to obtain a concentration
of approximately 108 CFU/mL. The 10 µL of bacterial
suspension was mixed with appropriate amounts of AA
and UA stock solution to reach final concentrations of acids
10, 20, 30, 40, and 50 µg/mL. Mixtures were incubated at
37 °C. After 0, 2, 4, 6, and 24 h, samples were diluted and
cultured on nutrient agar plates (BIOMED, Poland) for 18

557

WOJNICZ et al. / Turk J Biol

h at 37 °C to determine the number of bacterial cells (CFU/
mL). The control sample had no acids. The experiment was
repeated 3 times.
2.6. Bacterial culture conditions used in experiments
testing the impact of AA and UA on virulence factors
The bacteria were grown overnight at 37 °C in the presence
of AA and UA (10, 20, 30, 40, and 50 µg/mL). Next, bacteria
were harvested by centrifugation and resuspended in
PBS to reach a final concentration of approximately 106
CFU/mL. Control samples had neither AA nor UA. The
choice of these concentrations of triterpenes was due to
the low bioavailability of both AA and UA for eukaryotic
organisms (Jager et al., 2008).
2.7. Hemagglutination assay and expression of P-fimbriae
Equal volumes of bacterial suspension and 3% solution
of human erythrocytes with or without D-mannose were
mixed to determine the type of P-fimbrial mannoseresistant hemagglutination (Evans et al., 1980). The
experiment was repeated 3 times.
2.8. Curli fibers expression
Ten microliters of bacterial suspension was inoculated
onto a plate containing YESCA agar supplemented with
congo red. Curli-producing E. coli bound the congo red
dye and formed red colonies, whereas curli-negative
bacteria formed white colonies (Hammar et al., 1995). The
experiment was repeated 3 times.
2.9. Hemolytic activity
Ten microliters of bacterial suspension was spotinoculated onto sheep-blood agar plates. Alpha-hemolysin
production was confirmed by the appearance of a
hemolysis zone around the spot (Ghenghesh et al., 2009).
The experiment was repeated 3 times.
2.10. Swimming motility assay
Ten microliters of bacterial suspension was inoculated
onto motility plates (1% tryptone, 0.25% NaCl, and 0.3%
agar). After 24 h incubation at 37 °C, the diameters of the
swimming zones were measured (Sanchez-Torrez et al.,
2011). The presented results are the mean of 3 experiments.
2.11. Statistical analysis
The correlations between the concentrations of
pentacyclic triterpenes and the presence of virulence

factors (P-fimbriae, curli fibers, alpha-hemolysin) were
analyzed by assessing the distribution of the variables
using Pearson’s test. The differences in growth and motility
between rods exposed to AA and UA and those which
were unexposed were analyzed by a t-test for independent
samples. All tests were analyzed at the significance level P
< 0.05 using Statistica 7.1.
3. Results and discussion
3.1. Molecular characterization of bacterial strain
Pyelonephritis is a potentially life-threatening infection
that may lead to significant damage and kidney failure,
abscess formation, and sepsis. The important role of pap
and hlyA genes in the pathophysiology of pyelonephritis
caused by E. coli has been reported in several studies
(Moreno et al., 2005; Farshad and Emamghorashi, 2009).
In the current study, we found that among the examined
E. coli strains, the prevalence of virulence factors in genes
ranged from 0% for afa and draE to 100% for csgA. The
presence of the papC gene was detected in 17 (85%)
strains. The HlyA gene encoding alpha-hemolysin was
found in the genome of 12 E. coli rods (60%). All tested
UPECs were divided into 4 pathotypes on the basis of the
presence of virulence-related genes (Table 1). More than
half of the tested rods belonged to pathotype 1.
Our results highlight a higher frequency of csgA and
papC compared to the rest of the tested genes. This may
indicate that the presence of these 2 genes is characteristic
for the strains isolated from the upper parts of the urinary
tract. The importance of P-fimbriae coded by the pap
operon in pyelonephritis is well documented (Bogyiova
et al., 2002; Johnson et al., 2005). However, there are no
reports confirming that the csgA gene plays a significant
role in the pathogenesis of pyelonephritis. The presence
of curli fibers coded by this gene allows bacteria to bind
to the host cell membrane proteins, colonize the renal
tubular epithelium more efficiently, and produce biofilm.
The prevalence of the papC gene among clinical isolates
collected by us corresponds to results reported earlier
(Borisova et al., 2004; Wojnicz et al., 2012). However, the
distribution of the hlyA gene found in the current study
was higher than reported by Arisoy et al. (2008) and

Table 1. Pathotype patterns of E. coli strains.
Pathotype (genotype)

Numbers (%) of all
strains (n = 20)

Strain no.

Pathotype 1 (papC+, csgA+, hlyA+, afa-, draE-)

11 (55)

060, 11, 14, 192, 419, 448, 486, 529, 590, 679, 964

Pathotype 2 (papC+, csgA+, hlyA-, afa-, draE-)

6 (30)

30, 205, 399, 618, 652, 824

Pathotype 3 (papC-, csgA+, hlyA+, afa-, draE-)

1 (5)

794

Pathotype 4 (papC-, csgA+, hlyA-, afa-, draE-)

2 (10)

306, 338

+ present gene, - absent gene.
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Farshad et al. (2009). Due to its strongly toxic effect and
its ability to damage the membrane of renal cells, alphahemolysin may be an important factor in pyelonephritis
(Tseng et al., 2002; Kaper et al., 2004). On the other hand,
none of the tested strains possessed afa or draE genes. The
frequency of these genes in bacteria causing pyelonephritis
is very low (Matar et al., 2005; Santo et al., 2006). Such
high prevalence of csgA, papC, and hlyA genes among rods
tested in the current study indicates that the virulence traits
encoded by these genes are essential for bacteria causing
pyelonephritis. For this reason we decided to examine the
antibacterial activities of AA and UA against UPECs and
their effect on the synthesis of P-fimbriae and curli fibers,
production of alpha-hemolysin, and swimming motility.
3.2. Antibacterial activity
In our study we used AA, the therapeutic activity of
which is poorly described, and UA, the antimicrobial
action of which, mainly against gram-positive bacteria,
has been described in several reports (Chandramu et al.,
2003; Cunha et al., 2007; Fontanay et al., 2008; Kurek et
al., 2010). Table 2 summarizes the in vitro susceptibilities
of the 20 isolates of E. coli to AA and UA. As previously
identified (Wojnicz et al., 2012), MIC values were high
and ranged from 512 µg/mL to >1024 µg/mL. Cunha et
al. (2007) noted relatively low MIC values of UA against
gram-positive bacteria. This triterpene displayed the
most intense antibacterial effect against oral pathogens
Streptococcus mutans, Streptococcus mitis, Streptococcus
sanguinis, Streptococcus salivarius, Streptococcus sobrinus,
and Enterococcus faecalis, with MIC values ranging from
30 µg/mL to 80 µg/mL. UA was also active against B.
cereus, showing the MIC value of 20 µg/mL (Cunha et al.,
2010). Fontanay et al. (2008) noted very low MIC values
of UA for reference strains Staphylococcus aureus ATCC
25923 (8 µg/mL), S. aureus ATCC 29213 (8 µg/mL),

and E. faecalis ATCC 29212 (4 µg/mL). The MICs of UA
were much higher (≥256 µg/mL) against gram-negative
reference strains E. coli ATCC 25922, P. aeruginosa ATCC
27853 and clinical isolates of P. aeruginosa, penicillinaseproducing E. coli, gram-positive methicillin-resistant
S. aureus, and vancomycin-resistant enterococci. As we
expected, the MIC values of UA were also very high, and
for the majority of the tested strains were ≥1024 µg/mL.
Only 10% of rods (2 strains) were sensitive to the UA at
a concentration of 512 µg/mL. We also determined the
MIC values of AA and found that the growth of 30% of
UPECs (6 strains) was totally inhibited in the presence of
512 µg/mL of AA. Contrary to our results, Norzaharaini
et al. (2011) evaluated the inhibitory effect of AA against
both gram-negative (Helicobacter pylori ATCC 45903,
E. coli ATCC 29952, P. aeruginosa) and gram-positive (S
aureus, S. pneumoniae) strains at concentrations of 20 µg/
mL. This AA concentration suppressed the growth of all
the investigated bacteria except P. aeruginosa. Garo et al.
(2007) noted that the MIC of AA against P. aeruginosa was
128 µg/mL. Djoukeng et al. (2005) showed that the MICs
of AA fractions obtained from the extract of Syzygium
guineense were much higher for gram-negative Shigella
sonnei and E. coli strains in comparison with gram-positive
B. subtilis. These values were 30.0, 5.0, and 0.75 µg/mL,
respectively. Such differences in antigrowth activities of
UA and AA against gram-positive and gram-negative
bacteria may be caused by variations in the composition
and permeability of the external surface structures of these
microorganisms. The outer membrane of gram-negative
bacteria may limit the activity of pentacyclic triterpenes
(Horiuchi et al., 2007).
3.3. Effect of AA and UA on bacterial growth
The effects of AA and UA on the growth of E. coli strains
are shown in Figure 2. These results show that bacterial

Table 2. The MICs of AA and UA against E. coli strains.

Strain no.

Concentrations of acids (µg/mL)
AA

UA

Strain no.

Concentrations of acids (µg/mL)
AA

UA

060

1024

1024

448

>1024

>1024

11

512

>1024

486

512

>1024

14

>1024

512

529

>1024

1024

30

>1024

>1024

590

1024

1024

192

512

1024

618

512

1024

205

>1024

1024

652

1024

1024

306

1024

>1024

679

1024

>1024

338

1024

512

794

1024

1024

399

512

>1024

824

1024

1024

419

512

1024

964

1024

>1024
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Figure 2. Effect of AA (A) and UA (B) on bacterial growth. Values represent the mean
percentage of control viability (CFU/mL) for 20 E. coli strains. *: Result is statistically
significant (P < 0.05).

growth depends on both the incubation time of UPECs
in the presence of AA or UA and the concentration of
triterpenes. The mean number of bacterial cells (CFU/
mL) at time T0 was 5.98 × 106 (100% survival of bacteria).
Significantly increased survival of tested rods was observed
after 2 h of exposure to all concentrations of UA and 50 µg/
mL of AA (P < 0.05). A 4-h incubation of bacteria in the
presence of triterpenes caused a decrease in their growth.
However, the percentage of viable bacteria significantly
decreased only in suspensions containing AA (P < 0.05). The
survival of tested strains increased in 6-h bacterial cultures
in comparison with 4-h cultures, except for bacteria treated
with 50 µg/mL of UA. After 24 h of incubation, significant
reduction of bacterial growth was observed only in samples
containing AA at a concentration of 50 µg/mL and UA at
concentrations of 40 and 50 µg/mL (P < 0.05).
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The results obtained in this study show differences in
growth-inhibitory activities between AA and UA (Figure
2). The survival of bacteria incubated in the presence
of AA decreased significantly in comparison with the
survival of rods exposed to UA. This phenomenon may
be related to the chemical structure of the examined
triterpenes. AA and UA have similar chemical structures
(Figure 1), although it should be noted that the number of
methyl and hydroxyl groups is different in these 2 acids.
AA has 6 methyl groups attached to C4, C8, C10, C14,
C19, and C20, while UA contains 1 more methyl group at
the C4 position. AA possesses 3 hydroxyl groups attached
to carbon atoms 2, 3, and 23 (C2, C3, C23) of the cyclic
ring system; UA has only 1 hydroxyl group at C3. It is
interesting that in the current study AA has shown more
effective antigrowth activity than UA. Such an effect may
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statistical analysis of the results showed a significant
correlation only between the concentrations of UA and the
loss of P-fimbriae (P < 0.05). In the case of AA, the P-value
was greater than 0.05, and therefore the null hypothesis
(“variables dependent on each other”) was rejected. This
result means that the loss of P-fimbriae is independent of
the AA concentrations.
3.5. Curli fiber expression
The impact of AA and UA on the occurrence of curli
fibers is shown in Tables 3 and 4. The presence of the csgA
gene, which encodes the structural protein curli fimbriae,
was observed in all tested strains. Despite the presence
of the csgA gene, 2 strains did not possess curli fibers
and therefore formed white colonies on YESCA agar.
Inhibition of curli fimbriae synthesis after exposure to AA
was observed in 4 E. coli strains belonging to pathotype 1
(No. 11) and pathotype 2 (Nos. 30, 399, 618). Three E. coli
isolates (Nos. 060, 11, 618) did not possess curli fibers after
treatment with UA. The loss of congo red-binding abilities
by the tested rods was observed only at concentrations of
40 and 50 µg/mL of both acids used. We obtained similar
results in our previous research (Wojnicz et al., 2012).
Results of the current study indicate that AA and UA
have relatively similar inhibitory activities on curli fiber
synthesis, although it should be noted that AA caused the

be related to the presence of the hydroxyl group at position
C23 of AA (38). Research conducted by Wen et al. (2005)
on the relationships between structure and activities of
pentacyclic triterpenes showed that the A-ring structure
also has a significant impact on their biological activities.
3.4. Hemagglutination assay and expression of P-fimbriae
Of the 17 papC+, afa-, and draE- strains, 15 (88%) caused
agglutination of erythrocytes as a result of P-fimbriae
expression. The effects of AA and UA on hemagglutination
and expression of P-fimbriae are shown in Tables 3 and
4. The loss of hemagglutination abilities under the
action of AA was observed for 6 E. coli strains and for 5
rods incubated in the presence of UA. The E. coli strains
belonging to pathotype 1 (Nos. 060, 11, 529, 964) and
pathotype 2 (No. 824) were susceptible to both acids. Even
the lowest acid concentrations used (10 µg/mL) caused
inhibition of P-fimbriae expression in tested E. coli rods.
However, the most efficient inhibitory effect was observed
for higher AA and UA concentrations (40 and 50 µg/mL).
Very similar results were also obtained in our previous
study (Wojnicz et al., 2012); however, we did not consider
the genetic pathotypes in that study, but only analyzed
the strains phenotypically. The analysis of the results
presented in Tables 3 and 4 shows that the antifimbrial
activities of these acids are relatively similar. However,

Table 3. The loss of virulence factors by E. coli strains exposed to AA.
Concentrations of AA (µg/mL)
Virulence factor

P-fimbriae
(n = 15)
Curli fibers
(n = 18)
Alpha-hemolysin
(n = 11)

10

20

30

40

50

n

Strain no.

n

Strain no.

n

Strain no.

n

Strain no.

n

Strain no.

3

060, 11, 824

5

060, 11, 824,
529, 964

5

060, 11, 824,
529, 964

6

060, 11, 824,
529, 964, 590

6

060, 11, 824,
529, 964, 590

0

---

0

---

0

---

3

11, 30, 399

4

11, 30, 399, 618

0

---

0

---

1

192

2

192, 060

7

192, 060, 14, 419,
448, 679, 964

Table 4. The loss of virulence factors by E. coli strains exposed to UA.
Concentrations of UA (µg/mL)
10

Virulence factor
n
P-fimbriae
(n = 15)
Curli fibers
(n = 18)
Alpha-hemolysin
(n = 11)

3

Strain no.
11, 824, 529

20

30

40

50

n

Strain no.

n

Strain no.

n

Strain no.

n

Strain no.

5

11, 824, 529,
060, 964

5

11, 824, 529,
060, 964

5

11, 824, 529,
060, 964

5

11, 824, 529,
060, 964

0

---

0

---

0

---

1

11

3

060, 11, 618

0

---

0

---

0

---

4

14, 419,
448, 679

8

14, 419, 448, 679,
060, 192, 590, 964
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loss of curli fibers from cell surfaces of 7 strains, while
UA caused loss in only 4 cases. Moreover, the statistical
analysis of the data showed that the loss of curli fibers
remained in correlation only with UA (P < 0.05). The loss
of these adhesins by strains incubated in the presence of
AA is independent of its concentration (P > 0.05).
3.6. Hemolytic activity
The effects of AA and UA on alpha-hemolysin production
are shown in Tables 3 and 4. Of the hlyA+ strains, 11 out of
12 (73%) produced alpha-hemolysin. The inhibitory effect
of the acids was observed in 8 E. coli strains belonging to
pathotype 1 (Nos. 060, 14, 192, 419, 448, 590, 679, 964).
The strongest antihemolytic activities were obtained
during the treatment of tested bacterial strains with the
highest (50 µg/mL) concentrations of both acids. The
loss of alpha-hemolysin synthesis was also observed in
4 bacterial cultures exposed to UA, and in 2 bacterial
suspensions containing AA, at a concentration of 40 µg/
mL. At a concentration of 30 µg/mL, only AA inhibited
the release of the toxin to the bacterial medium. Based on
statistical analysis, we found that a correlation between
concentration and the loss of hemolytic activity is present
only in UA. No correlation was noticed for AA (P > 0.05),
which means that the loss of the toxin synthesis can be
observed in low as well as higher concentrations of this
triterpene.
3.7. Swimming motility
The ability to move was observed in 14 (70%) out of
20 E. coli strains. The results are shown in Figure 3.
The mean swimming zone diameter of bacteria in the
control sample was 29.8 ± 2.0 mm. The diverse effect of
both acids on swimming motility of UPEC strains was

recorded. Bacterial movement of all strains was reduced
at all concentrations of both triterpenes, but results were
statistically significant only for the highest concentrations
of AA and UA (P < 0.05). The mean zone diameters for
bacteria treated with AA and UA at concentrations of 40
µg/mL were 23.1 ± 3.4 and 23.6 ± 3.4 mm, respectively. A
slightly stronger inhibitory effect was noticed for bacteria
incubated in the presence of both acids at a concentration
of 50 µg/mL. The zone diameters were 22.2 ± 3.1 and 21.1
± 2.9 mm for AA and UA, respectively.
The above results show that triterpenes do not differ
significantly from each other in their inhibitory effects
on bacterial virulence factors. Both AA and UA were
most effective in reducing bacterial swimming motility
and the loss of P-fimbriae. The movement of all strains
was decreased at each concentration of both AA and
UA, but statistically significant results occurred at only
the 2 highest concentrations (P < 0.05). Strong anti–Pfimbrial effect was also observed in all concentrations
of both triterpenes. The loss of curli fibers and alphahemolysin synthesis was correlated only with the highest
concentrations of UA (P < 0.05). No statistical significance
between AA concentration and the suppression of these
virulence factors was found (P > 0.05).
In this study, a lower level of antigrowth activity
was shown for UA than AA. This result may be due to a
smaller number of hydroxyl groups in the A-ring of UA
in comparison with AA. UA possesses only one hydroxyl
group and therefore has a more hydrophobic character
than AA. Hence, the penetration of UA across the outer
membrane of E. coli strains is hindered. Raetz and
Whitfield (2002) established that lipid A (a component
of lipopolysaccharide) anchored in the outer membrane
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Figure 3. Effect of AA and UA on swimming motility. Values represent the mean value of
swimming zone diameter (mm) for 14 E. coli strains. Bars indicate standard deviations.
*:Result is statistically significant (P < 0.05).
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is a barrier inhibiting the penetration of hydrophobic
substances. AA has a more hydrophilic character because
of the 3 hydroxyl groups in its structure and therefore
can more easily penetrate the outer membrane, thus
demonstrating higher antibacterial activity.
In conclusion, pentacyclic triterpenes may serve
as supplementary agents that could improve standard
conventional antibacterial therapy in UTIs. However, the
action of pentacyclic triterpenes on bacterial cells is still
not fully known and requires further investigation.
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